StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2023 - 11 - 06
1
2022 - 12 - 23
1
2022 - 05 - 31
2
2022 - 04 - 20
1
2022 - 04 - 19
1
2021 - 12 - 16
1
2021 - 05 - 21
1
2021 - 05 - 19
1
2021 - 03 - 15
1
Sector
Health technology
10
Tags
Alliances
16
Antibody
7
Application
11
Approval
20
Asia
15
Biotech
6
Biotech-bay
10
Biotech-beach
17
Cabometyx
7
Cancer
34
Cell carcinoma
7
Children
7
Clinical-trials-phase-ii
10
Clinical-trials-phase-iii
23
Collaboration
15
Covid
11
Covid-19
10
Disease
33
Drug
29
Earnings
23
Events
8
Expected
7
Fda
17
Financial
17
Financial results
13
Gene therapies
6
Gene therapy
6
Genetown
22
Global
51
Growth
29
Hereditary angioedema
8
Injection
6
Japan
7
License
13
Liver
16
Market
85
Money
11
N/a
185
Nivolumab
6
Partnership
6
People
7
Pharmaceutical
17
Phase 2
6
Phase 3
19
Positive
14
Product-news
10
Rare
11
Reach
12
Renal
7
Report
46
Research
41
Results
58
Sars-cov-2
6
Study
8
Takhzyro
7
Therapeutics
37
Therapy
43
Treatment
50
Trial
36
Vaccine
27
Entities
Abbott laboratories
1
Agilent technologies, inc.
1
Arcturus therapeutics holdings inc.
1
Glaxosmithkline plc
2
Johnson & johnson
4
Moderna, inc.
2
Novartis ag
1
Novavax, inc.
1
Sanofi
2
Takeda pharmaceutical company limited
10
Teva pharmaceutical industries limited
1
Thermo fisher scientific inc
1
Viatris inc.
1
Symbols
ABB
31
ABLZF
16
ABT
32
ADMP
11
APDN
15
ARVL
39
AVIR
9
AZN
8
BDX
31
BIO
8
BNTX
50
COCP
8
CODX
8
CSCO
15
CVAC
19
DD
10
DHR
12
DVAX
46
ENTA
9
FNCTF
29
GE
14
GENE
10
GILD
16
GLAXF
15
GOVX
16
GSK
25
HGEN
11
HLTH
17
HON
33
IFRX
12
IVVD
9
JNJ
227
LHDX
9
LLY
48
MDT
16
MMM
16
MRK
10
MRNA
74
MSFT
11
NRXP
21
NVAX
93
NVS
12
OCGN
10
ORCL
17
PFE
41
PHG
10
QDEL
18
QGEN
12
RDHL
16
ROK
9
SAP
17
SAPGF
9
SNY
111
SNYNF
75
SRNE
16
TAK
10
TAYD
21
TMO
40
VERU
25
VXRT
19
Exchanges
Nasdaq
6
Nyse
10
Crawled Date
2023 - 11 - 06
1
2022 - 12 - 23
1
2022 - 05 - 31
2
2022 - 04 - 20
1
2022 - 04 - 19
1
2021 - 12 - 16
1
2021 - 05 - 21
1
2021 - 05 - 19
1
2021 - 03 - 15
1
Crawled Time
05:00
1
06:00
1
09:00
3
12:00
1
13:00
1
15:00
1
18:00
1
19:00
1
Source
www.biospace.com
6
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Covid-19
symbols :
Tak
save search
COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published:
2023-11-06
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
17.51%
|
O:
0.41%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
22.15%
|
O:
0.11%
H:
0.33%
C:
-0.98%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
42.1%
|
O:
0.22%
H:
1.49%
C:
-0.33%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-3.43%
|
O:
0.44%
H:
0.22%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.97%
|
O:
0.24%
H:
0.18%
C:
0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.48%
|
O:
0.18%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.26%
|
O:
0.55%
H:
0.3%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
12.24%
|
O:
-0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.37%
|
O:
-1.32%
H:
0.0%
C:
0.0%
covid-19
Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published:
2022-12-23
(Crawled : 15:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
12.85%
|
O:
-3.13%
H:
0.0%
C:
-0.23%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-14.14%
|
O:
0.13%
H:
0.71%
C:
0.65%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.57%
|
O:
-0.14%
H:
0.28%
C:
-0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.7%
|
O:
-0.23%
H:
0.0%
C:
0.0%
covid-19
drug
research
global
disease
report
impact
gastrointestinal
market
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
Published:
2022-05-31
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.3%
|
O:
-2.24%
H:
0.35%
C:
-0.14%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-26.41%
|
O:
5.09%
H:
0.0%
C:
0.0%
covid-19
japan
vaccine
authorization
Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna
Published:
2022-05-31
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.3%
|
O:
-2.24%
H:
0.35%
C:
-0.14%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-26.41%
|
O:
5.09%
H:
0.0%
C:
0.0%
covid-19
japan
vaccine
authorization
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
Published:
2022-04-20
(Crawled : 12:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-8.5%
|
O:
1.17%
H:
0.68%
C:
0.27%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.98%
|
O:
1.06%
H:
1.14%
C:
0.91%
ARCT
4
|
$25.995
-1.23%
-1.25%
630K
|
Health Technology
|
3.1%
|
O:
-20.04%
H:
28.04%
C:
21.44%
covid-19
arct-154
vaccine
mrna
phase 3
Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published:
2022-04-19
(Crawled : 06:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.54%
|
O:
-2.23%
H:
0.0%
C:
0.0%
covid-19
nuvaxovid
vaccine
approval
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published:
2021-12-16
(Crawled : 05:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-2.22%
|
O:
1.18%
H:
0.0%
C:
0.0%
NVAX
|
$3.99
2.57%
2.51%
2.9M
|
Health Technology
|
-97.66%
|
O:
5.55%
H:
0.0%
C:
0.0%
covid-19
new drug
application
drug
approval
covid
vaccine
submission
Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan
Published:
2021-05-21
(Crawled : 09:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-23.56%
|
O:
0.75%
H:
0.63%
C:
-0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-13.54%
|
O:
0.15%
H:
0.82%
C:
-0.22%
covid
vaccine
approval
covid-19
Global Medical Enzyme Technology Market (2021 to 2028) - COVID-19 Impact and Analysis
Published:
2021-05-19
(Crawled : 18:00)
- prnewswire.com
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
19.83%
|
O:
-0.6%
H:
1.38%
C:
1.12%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-23.2%
|
O:
-0.52%
H:
0.35%
C:
-0.06%
A
|
$132.73
0.22%
0.0%
1.3M
|
Health Technology
|
3.09%
|
O:
-0.89%
H:
2.1%
C:
2.05%
covid
technology
covid-19
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Published:
2021-03-15
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-28.2%
|
O:
1.36%
H:
1.12%
C:
0.96%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.32%
|
O:
0.09%
H:
0.57%
C:
0.42%
covid
vaccine
covid-19
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.